Devices · Labs · Equipment

Strategy for
Medtech.

Our medtech practice serves emerging innovation and large medtech across devices, medical equipment, and diagnostics. Common strategy questions range from market assessments to business models and pricing approaches.

FEATURED PERSPECTIVE

  • Biopharma , 
  • Medtech , 
  • Digital , 

Keys to harnessing the value of digital biomarkers in clinical trials

Digital biomarkers are no longer just a pipe dream—they are here, and their use is potentially at an inflection point. However, successful implementation requires more than enthusiasm; it demands thoughtful strategies tailored to each clinical innovation, therapeutic area, and digital tool.

Read the analysis →

"A compelling value proposition alone is not sufficient."

— Recon analysis

Why the Best AI Won’t Win in Healthcare

  • Biopharma , 
  • Payers , 
  • Providers , 
  • Medtech , 
  • Digital
As advanced AI becomes widely accessible, healthcare companies can no longer rely on superior technology alone for lasting advantage. Instead, they need a coherent AI strategy built around five interconnected choices. Harvard Business Review article.

Read more

Stylized representation of digital health

Keys to harnessing the value of digital biomarkers in clinical trials

  • Biopharma , 
  • Medtech , 
  • Digital , 
Digital biomarkers are no longer just a pipe dream—they are here, and their use is potentially at an inflection point. However, successful implementation requires more than enthusiasm; it demands thoughtful strategies tailored to each clinical innovation, therapeutic area, and digital tool.

Read more

The road ahead for genomic testing

  • Biopharma , 
  • Payers , 
  • Medtech , 
New molecular diagnostics, especially tests based on next-generation s…

Read more

SELECTED CASE STUDIES

How we've helped Medtech

Representative engagements, anonymized. Each pairs deep sector knowledge with rigorous, structured analysis.

Molecular diagnostics growth strategy

A molecular diagnostics developer had more new-test opportunities than it could fund and no shared view of which it was equipped to win or whether the economics could work.

New test portfolio prioritization

Device market entry strategy

An early-stage technology could digitize a large analog device market but needed the board aligned on which market to enter first, and on what terms to engage incumbents, before its Series A ran out.

Digital diagnostic business case

Growth strategy for point-of-care testing

Post pandemic an innovative diagnostics platform company wanted to dramatically increase its market by targeting retail clinics for its point-of-care diagnostics platform

Growth, product market fit, value proposition